John B. Bode - 12 Jul 2024 Form 4 Insider Report for ZEVRA THERAPEUTICS, INC. (ZVRA)

Role: Director
Signature: /s/ Timothy J. Sangiovanni, Attorney-in-Fact for John B. Bode
Issuer symbol: ZVRA
Transactions as of: 12 Jul 2024
Net transactions value: +$58,661
Form type: 4
Filing time: 15 Jul 2024, 16:10:52 UTC
Previous filing: 15 May 2024
Next filing: 21 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ZVRA	Common Stock	Purchase	$58,661	+10,000	+50%	$5.87	30,000	12 Jul 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.81 to $5.93, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.81 to $5.93, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.